New kind of "designer" immune cells clear baby's leukemia
22 minutes ago link
By Kate Kelland, Health and Science Correspondent
LONDON, Nov 5 (Reuters) - A baby whom doctors thought almost certain to die has been cleared of a previously incurable leukemia in the first human use of an "off-the-shelf" cell therapy from Cellectis that creates designer immune cells. The gene-edited cell treatment was prepared by scientists at GOSH and University College London (UCL) together with the French biotech firm Cellectis, which is now funding full clinical trials. "This is a landmark in the use of new gene engineering technology and the effects for this child have been staggering," said Waseem Qasim, a professor of Cell and Gene Therapy at UCLA andimmunologist at GOSH who worked on her medical team. Cellectis working with the U.S. giant Pfizer , as well
as Novartis believes its method is faster and cheaper than creating single patient-specific gene therapies
By the time there is a run-up for ER, Upgrades before ER and After ER and expected sales in $billions on their new Cystic Fibrosis drug that will be announced for the first time at up coming earmings..back to $140's is not out of the question.